Foreword

Philen RM , Posada de la Paz M . Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1999, World Health Organization meeting report . Semin Arthritis Rheumat 1993; 23: 104-124 .

Abaitua Borda I et al. Toxic Oil syndrome mortality; the first 13 years . Int J Epidemiol 1998; 27: 1057-1063 .

Doll R . The aetiology of the Spanish Toxic Syndrome: Interpretation of the epidemiological evidence. World Health Organization: Copenhagen , 1985 (Report nr SPA/CEH 502).

Tabuenca JM . Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline . Lancet 1981; 2: 567-568 .

Grandjean P , Tarkowski S . Subgroup discussion. In: World Health Organization , eds. Toxic Oil Syndrome: Mass Food Poisoning in Spain. World Health Organization Regional Office for Europe: Copenhagen , 1984; pp. 17-27.

Kilbourne EM et al. Clinical epidemiology of toxicoil syndrome. Manifestations of a new illness . New Engl J Med 1983; 309: 1408-1414 .

Toxic Epidemic Syndrome Study Group . Toxic epidemic syndrome, Spain, 1981 . Lancet 1982; 2: 697-702 .

Serrano Rios M , Faro Leal V . Clinical and pathological features of TOS. In: World Health Organization , ed. Toxic Oil Syndrome: Mass Food Poisoning in Spain. World Health Organization Regional Office for Europe: Copenhagen , 1984; pp. 53-74.

RicoyJR et al. Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain . Brain 1983; 106: 817-835 .

Martinez Tello FJ et al. Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain . Virchows Archiv A, [Pathological Anatomy and Histology] 1982; 397: 261-285 .

Posada de la Paz M et al. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain . Epidemiology 1994; 5: 404-409 .

Kilbourne EM et al. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain . Am J Epidemiol 1988; 127: 1210-1227 .

Posada de la Paz M . Diet and food contaminants. In: Steenland K , Savitz DA , eds. Topics in Environmental Epidemiology. Oxford University Press, New York 1997; pp. 65-88.

World Health Organization . Report on the 24th Meeting of the WHO/FIS Scientific Committee for the Toxic Oil Syndrome. World Health Organization: Copenhagen , 1998 (unpublished document).

Gallardo S et al. Immunological basis of toxic oil syndrome (TOS) . Toxicology 1994; 93: 289-299 .

Del Pozo V et al. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism . Toxicology 1997; 118: 61-70 .

Bioque G et al. Metabolism of N-phenyllinoleamide by rat liver . J Chromatogr 1993; 615: 191-196 .

Ramis Pedromingo I et al. Cyclooxygenase product of metabolism of arachidonic acid in mouse macrophages exposed to N-phenyllinoleamide from toxic oil samples . Prostagland Leukotr Essent Fatty Acids 1990; 39: 147-149 .

Ten RM et al. Participation of eosinophils in the toxic oil syndrome . Clin Exp Immunol 1990; 82: 313-317 .

Toxic Oil Syndrome : Metabolic Polymorphisms as Risk Factors. A Molecular Approach to the Xenobiotic Metabolism . Presented at the IEA European Regional Meeting. The Health of Populations in a Changing Europe. Munster, Germany, September 3-6, 1997.

Aldridge WM . Experimental studies . WHO Regional Publisher Euro Series 1992; 42: 67-97 .

Kilbourne EM . Eosinophilia-myalgia syndrome: coming to grips with a new illness . Epidemiol Rev 1992; 14: 16-36 .

Hill RH et al. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino) 1,2-propanediol . Arch Environ Contaminat Toxicol 1995; 28: 259-264 .

Posada de la Paz M et al. Epidemiologic evidence for a new class of compounds associated with Toxic Oil Syndrome . Epidemiology 1999; 10: 130-134 .

Vioque E , Ventura Diaz M . Presencia de una fraccion anormal de hidrocarburos en algunas partidas de aceite de colza crudo desnaturalizado con anilina . Grasa y Aceites 1983; 34: 188-196 .